The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial | Synapse
April 29, 2021Open Access
The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Clinicaltrials.gov, NCT04692415 . Retrospectively registered on December 31th 2020.